Hepatitis B Vaccine (Recombinant) Completed Phase 2 Trials for Viral Hepatitis B / Hepatocellular,Carcinoma Prevention

IndicationsStatusPurposePhase
CompletedPrevention2
clinicaltrials.gov IdentifierTitleDrugs
NCT00322361Modified Process Hepatitis B Vaccine in Healthy Neonates (V232-056)
NCT01777295Development of Read-outs in Healthy, Hepatitis B Virus Naive Adults Vaccinated With the Hepatitis B Surface Antigen (HBsAg) in Combination With a GlaxoSmithKline (GSK) Biologicals' Adjuvant System
NCT00805389Study to Compare the Efficacy of GSK Biologicals' Adjuvants in Combination With the Antigen of the Hepatitis B Vaccine
NCT00107042Effectiveness of Two Hepatitis B Vaccines in HIV-negative Youths
NCT00697125Immunogenicity & Reactogenicity of Various Formulations of Recombinant Hepatitis B Vaccine With Different Adjuvants